Geniposide reduces α-synuclein by blocking microRNA-21/lysosome-associated membrane protein 2A interaction in Parkinson disease models

Brain Research

Volumn 1644, Issue , 2016, Pages 98-106

  Su, Chunhe ^a   Yang, Xiaopeng ^a   Lou, Jiyu ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Geniposide; LAMP2A; MIR 21; Parkinson disease; synuclein

Indexed keywords

ALPHA SYNUCLEIN; GENIPOSIDE; LUCIFERASE; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2A; MESSENGER RNA; MICRORNA 21; UNCLASSIFIED DRUG; IRIDOID; LAMP2 PROTEIN, HUMAN; MICRORNA; MIRN21 MICRORNA, HUMAN; NEUROPROTECTIVE AGENT; TYROSINE 3 MONOOXYGENASE;

3' UNTRANSLATED REGION; A WAVE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUCIFERASE ASSAY; MOUSE; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RNA BINDING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBSTANTIA NIGRA; UPREGULATION; WESTERN BLOTTING; ANIMAL; DISEASE MODEL; DOPAMINERGIC NERVE CELL; DRUG EFFECTS; METABOLISM; PARKINSONISM; TUMOR CELL LINE;

ALPHA-SYNUCLEIN; ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DOPAMINERGIC NEURONS; HUMANS; IRIDOIDS; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 2; MICE; MICRORNAS; NEUROPROTECTIVE AGENTS; PARKINSON DISEASE; PARKINSONIAN DISORDERS; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 84969695747     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2016.05.011     Document Type: Article

References (33)

1. Abeliovich, A., 2010. A MicroRNA feedback circuit in midbrain dopamine neurons. In: Christen, Y. (Ed.), Macro Roles for MicroRNAs in the Life and Death of Neurons, Vol., ed.-eds. Springer, pp. 27-33.
2. A. Abeliovich, Y. Schmitz, I. Fariñas, D. Choi-Lundberg, W.-H. Ho, P.E. Castillo, N. Shinsky, J.M.G. Verdugo, M. Armanini, and A. Ryan Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system Neuron 25 2000 239 252
3. L. Alvarez-Erviti, Y. Seow, A.H. Schapira, M.C. Rodriguez-Oroz, J.A. Obeso, and J. Cooper Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease Cell Death Dis. 4 2013 e545
4. E. Arias, and A.M. Cuervo Chaperone-mediated autophagy in protein quality control Curr. Opin. Cell Biol. 23 2011 184 189
5. P.K. Auluck, H.E. Chan, J.Q. Trojanowski, V.M.-Y. Lee, and N.M. Bonini Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson's disease Science 295 2002 865 868
6. H. Braak, K. Del Tredici, U. Rüb, R.A. de Vos, E.N.J. Steur, and E. Braak Staging of brain pathology related to sporadic Parkinson's disease Neurobiol. Aging 24 2003 197 211
7. M.-C. Chartier-Harlin, J. Kachergus, C. Roumier, V. Mouroux, X. Douay, S. Lincoln, C. Levecque, L. Larvor, J. Andrieux, and M. Hulihan α-Synuclein locus duplication as a cause of familial Parkinson's disease Lancet 364 2004 1167 1169
8. Q.C. Chen, W.Y. Zhang, H. Kim, I.S. Lee, Y. Ding, U.J. Youn, S.M. Lee, M. Na, B.S. Min, and K. Bae Effects of gardeniae fructus extract and geniposide on promoting ligament cell proliferation and collagen synthesis Phytother. Res. 24 2010 S1 S5
9. Y. Chen, Y. Zhang, L. Li, and C. Hölscher Neuroprotective effects of geniposide in the MPTP mouse model of Parkinson's disease Eur. J. Pharmacol. 2015
10. K.A. Conway, S.-J. Lee, J.-C. Rochet, T.T. Ding, R.E. Williamson, and P.T. Lansbury Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy Proc. Natl. Acad. Sci. USA 97 2000 571 576
11. A.M. Cuervo, L. Stefanis, R. Fredenburg, P.T. Lansbury, and D. Sulzer Impaired degradation of mutant α-synuclein by chaperone-mediated autophagy Science 305 2004 1292 1295
12. R. Fiore, G. Siegel, and G. Schratt MicroRNA function in neuronal development, plasticity and disease Biochim. Biophys. Acta - Gene Regul. Mech. 1779 2008 471 478
13. L.B. Frankel, N.R. Christoffersen, A. Jacobsen, M. Lindow, A. Krogh, and A.H. Lund Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells J. Biol. Chem. 283 2008 1026 1033
14. C. Gao, Y. Liu, Y. Jiang, J. Ding, and L. Li Geniposide ameliorates learning memory deficits, reduces tau phosphorylation and decreases apoptosis via GSK3β pathway in streptozotocin-induced alzheimer rat model Brain Pathol. 24 2014 261 269
15. X. Ge, Z. Han, F. Chen, H. Wang, B. Zhang, R. Jiang, P. Lei, and J. Zhang MiR-21 alleviates secondary blood-brain barrier damage after traumatic brain injury in rats Brain Res. 1603 2015 150 157
16. S. Ghavami, S. Shojaei, B. Yeganeh, S.R. Ande, J.R. Jangamreddy, M. Mehrpour, J. Christoffersson, W. Chaabane, A.R. Moghadam, and H.H. Kashani Autophagy and apoptosis dysfunction in neurodegenerative disorders Prog. Neurobiol. 112 2014 24 49
17. P. Kaur, A. Armugam, and K. Jeyaseelan MicroRNAs in neurotoxicity J. Toxicol. 2012 2012
18. Kaushik, S., Cuervo, A., 2008. Chaperone-mediated autophagy. In: Walker, J.M. (Ed.), Autophagosome and Phagosome, Vol., ed.-eds. Springer, pp. 227-244.
19. S.K. Khoo, L.A. Neuman, L. Forsgren, D. Petillo, and P. Brundin Could miRNA expression changes be a reliable clinical biomarker for Parkinson's disease? Neurodegener. Dis. Manag. 3 2013 455 465
20. A.E. Lang, and A.M. Lozano Parkinson's disease N. Engl. J. Med. 339 1998 1044 1053
21. G. Li, H. Yang, D. Zhu, H. Huang, G. Liu, and P. Lun Targeted suppression of chaperone-mediated autophagy by miR-320a promotes α-synuclein aggregation Int. J. Mol. Sci. 15 2014 15845 15857
22. C. Lv, L. Wang, X. Liu, S. Yan, S.S. Yan, Y. Wang, and W. Zhang Multi-faced neuroprotective effects of geniposide depending on the RAGE-mediated signaling in an Alzheimer mouse model Neuropharmacology 89 2015 175 184
23. S.K. Mak, A.L. McCormack, A.B. Manning-Boǧ, A.M. Cuervo, and D.A. Di Monte Lysosomal degradation of α-synuclein in vivo J. Biol. Chem. 285 2010 13621 13629
24. M.E. Mercado-Pimentel, B.C. Onyeagucha, Q. Li, A.C. Pimentel, J. Jandova, and M.A. Nelson The S100P/RAGE signaling pathway regulates expression of microRNA-21 in colon cancer cells FEBS Lett. 589 2015 2388 2393
25. S.P. Presgraves, T. Ahmed, S. Borwege, and J.N. Joyce Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists Neurotox. Res. 5 2003 579 598
26. S. Roy, S. Khanna, S.-R.A. Hussain, S. Biswas, A. Azad, C. Rink, S. Gnyawali, S. Shilo, G.J. Nuovo, and C.K. Sen MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue Cardiovasc. Res. 2009
27. T. Saha LAMP2A overexpression in breast tumors promotes cancer cell survival via chaperone-mediated autophagy Autophagy 8 2012 1643 1656
28. T. Saha, S. Ghosh, A. Vassilev, and M.L. DePamphilis Ubiquitylation, phosphorylation and Orc2 modulate the subcellular location of Orc1 and prevent it from inducing apoptosis J. Cell Sci. 119 2006 1371 1382
29. L.F. Sempere, S. Freemantle, I. Pitha-Rowe, E. Moss, E. Dmitrovsky, and V. Ambros Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation Genome Biol. 5 2004 R13
30. Y. Suzuki, K. Kondo, Y. Ikeda, and K. Umemura Antithrombotic effect of geniposide and genipin in the mouse thrombosis model Planta Med. 67 2001 807 810
31. E.M. Valente, P.M. Abou-Sleiman, V. Caputo, M.M. Muqit, K. Harvey, S. Gispert, Z. Ali, D. Del Turco, A.R. Bentivoglio, and D.G. Healy Hereditary early-onset Parkinson's disease caused by mutations in PINK1 Science 304 2004 1158 1160
32. Z.-H. Wang, J.-L. Zhang, Y.-L. Duan, Q.-S. Zhang, G.-F. Li, and D.-L. Zheng MicroRNA-214 participates in the neuroprotective effect of Resveratrol via inhibiting α-synuclein expression in MPTP-induced Parkinson's disease mouse Biomed. Pharmacother. 74 2015 252 256
33. M. Xilouri, O.R. Brekk, D. Kirik, and L. Stefanis LAMP2A as a therapeutic target in Parkinson disease Autophagy 9 2013 2166 2168